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Optogenetic control of the heart is an emergent technology that offers unparalleled
spatio-temporal control of cardiac dynamics via light-sensitive ion pumps and channels
(opsins). This fast-evolving technique holds broad scope in both clinical and basic
research setting. Combination of optogenetics with optical mapping of voltage or
calcium fluorescent probes facilitates ‘all-optical’ electrophysiology, allowing precise
optogenetic actuation of cardiac tissue with high spatio-temporal resolution imaging
of action potential and calcium transient morphology and conduction patterns. In
this review, we provide a synopsis of optogenetics and discuss in detail its use
and compatibility with optical interrogation of cardiac electrophysiology. We briefly
discuss the benefits of all-optical cardiac control and electrophysiological interrogation
compared to traditional techniques, and describe mechanisms, unique features and
limitations of optically induced cardiac control. In particular, we focus on state-of-the-art
setup design, challenges in light delivery and filtering, and compatibility of opsins with
fluorescent reporters used in optical mapping. The interaction of cardiac tissue with light,
and physical and computational approaches to overcome the ‘spectral congestion’ that
arises from the combination of optogenetics and optical mapping are discussed. Finally,
we summarize recent preclinical work applications of combined cardiac optogenetics
and optical mapping approach.
Keywords: optogenetic, optical mapping, fluorescence, cardiac, action potential, calcium, conduction (action
potential), arrhythmias
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INTRODUCTION
Over the past 30 years high resolution camera technologies and
development of several potentiometric and intracellular calcium
sensors has led to optical mapping becoming a valuable tool in
cardiac research (Salama et al., 1987; Boukens and Efimov, 2014).
Electrical conduction, action potential and calcium transient
morphology can be directly measured, quantified, and tracked
across multicellular cardiac preparations in high spatio-temporal
resolution, unparalleled by traditional electrode techniques
(Herron et al., 2012; Yu et al., 2014). Optical mapping has
hence played a pivotal role in cardiac research, providing several
insights into physiology and pathophysiology of the heart (Jalife,
2003; Myles et al., 2012; Syeda et al., 2016; Winter et al., 2018).
Conversely, optogenetics shifts light to an actuator role to
control and tune EP behavior through genetically introducing
photosensitive ion channels and pumps (opsins), able to
depolarize and hyperpolarize excitable cells. This emergent
technology, with its foundations in neuroscience, is now
increasingly exploited by heart researchers. Optogenetic pacing
of cardiac preparations has now been reported in several
experimental models (Park et al., 2014; Vogt et al., 2015;
Zhu et al., 2016; Nyns et al., 2017). Beyond rhythm control,
optogenetics has been used to terminate arrhythmias in both
ex vivo and in vivo rodent hearts (Bruegmann et al., 2016,
2018; Nyns et al., 2017), suppress and manipulate rotors in
cardiomyocyte monolayers (Feola et al., 2017; Watanabe et al.,
2017) and elucidate the function of both cardiomyocyte (Wang
et al., 2017) and non-cardiomyocyte (Hulsmans et al., 2017)
cellular subpopulations in the heart. Hence, optogenetics presents
a pivotal emergent technology for basic research, while some of its
unique features make it a potentially transformative clinical tool
for both pacing and arrhythmia termination.
Combination of optogenetics with optical imaging of cellular
monolayers and whole hearts allows ‘all-optical’ cardiac EP
investigation (Figure 1); an approach that has seen growing
application in cardiac research (Entcheva, 2013; Nussinovitch
and Gepstein, 2015b; Entcheva and Bub, 2016). Owing to
contactless operation and high spatio-temporal resolution, all-
optical systems are uniquely capable of high throughput control
and study of complex phenomena that can arise in excitable
media. High spatio-temporal understanding of cardiac behavior
in response to optical actuation, aside from providing an
invaluable research tool, is also vital if optogenetics is to transition
to clinical utility.
The requirement and employment of all-optical approach has
been expansively presented in recent reviews (Entcheva and Bub,
2016; Crocini et al., 2017). In the present article, we discuss
the basic tools of optogenetics (opsins), and optical mapping
(voltage and calcium sensors). We focus on their dual use in
all-optical setups, including their mechanisms of action, delivery
to cardiac tissue, spectral compatibility and highlight technical
considerations and advances that have made all-optical systems
practical. Additionally, benefits of all-optical cardiac control
and EP interrogation when compared to traditional contact
techniques are discussed, and we highlight recent applications of
combined cardiac optogenetics and optical mapping approaches.
TOOLS OF OPTOGENETICS – OPSINS
The development of optogenetics as a valuable research tool
stems from the discovery and cloning of microbial opsins that
behave as light-gated ionic channels in the early to mid-2000s –
Channelrhodopsins (Nagel et al., 2003, 2005; Boyden et al.,
2005). In particular Channelrhodopsin2 (ChR2), and variants
thereof, is by far the most utilized opsin in optogenetics. On
excitation by blue light (∼470 nm) of threshold irradiance, ChR2
opens as its covalently bound photosensitive chromophore, all-
trans retinal, isomerizes (Nagel et al., 2003). The opening of
the channel allows ions, including Na+, to cross the cellular
membrane, as occurs in phase 0 of the action potential, initiating
depolarization. Hence, cells expressing ChR2 can be effectively
stimulated with blue light, initiating and/or prolonging the action
potential (Figure 2A). As well as being light sensitive, ChR2 also
acts in a voltage dependent manner, with decreasing conductance
at more positive membrane potentials and a reversal potential
near 0mV (Lin, 2010; Park et al., 2014).
Enhancement of the native properties of ChR2 is vital for
the future use of optogenetics in cardiac tissue, due to relatively
small currents generated by wild type ChR2 (steady state current
∼0.25 nA) and large absorption and scattering of visible light
by biological chromophores. This limits optical penetration
depth, preventing transmural opsin activation from deep tissue.
Deep activation would be advantageous for synchronous cardiac
activation and has been demonstrated as an important factor
in successful re-entry termination (Karathanos et al., 2016;
Watanabe et al., 2017). One possible method to realize deep
tissue activation is red-shifting of the excitation window toward
the ‘biological window’ of 650–1350 nm, where the extinction
coefficient of biological tissue is greatly reduced (Smith et al.,
2009). Light in this wavelength range can penetrate a few
centimeters into the cardiac tissue and thus more light can
reach and activate deep tissue opsins. Furthermore, decreasing
the threshold irradiance required for photocurrent activation
and/or increasing channel conductance or opening times, can
aid deep tissue activation and reduce energy requirements in
optogenetic applications.
Hence, since its isolation and cloning, ChR2 has undergone
several alterations including variants with enhanced conductance
[ChR2-H134R (Nagel et al., 2005), ChR2-T159C (Berndt
et al., 2011), ChR2-XXL (Dawydow et al., 2014)], Ca2+
permeability [CatCh (Kleinlogel et al., 2011)] and red shifted
spectral properties [ReaChR (Lin et al., 2013)]. Additionally,
channelrhodopsins separate from ChR2 have been cloned from
distinct algae species and subsequently optimized [CheRiff
(Hochbaum et al., 2014)], while chimeras of ChR1 and ChR2
have also demonstrated enhanced photocurrents [ChIEF (Lin
et al., 2009)]. These developments have led to a plethora of
available depolarizing opsins with diverse spectral and kinetic
properties (Schneider et al., 2015). Equally, it has been shown
how exogenously supplemented all-trans retinal can significantly
increase light sensitivity of ChR2, although concentration
dependent cytotoxic effects were also observed (Yu et al., 2015).
An important factor in enhancing the photocurrent of native
Channelrhodopsins is the effects mutagenesis can have on the
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FIGURE 1 | All-optical electrophysiology. Cardiac preparations treated with opsins and sensors allow simultaneous optically driven control of the heart (pacing or
modulation of the action potential) and optical recording of action potential or calcium handling across the myocardium.
photocycle kinetics. By prolonging channel opening times after
the cessation of light activation, light sensitivity can be improved
by a short pulse leading to a long-lasting photocurrent, e.g.,
ChR2-D156A which exhibits a dark off time of > 150 s (Bamann
et al., 2010). However, significant slowing of the channel kinetics
is detrimental to dynamic initiation and control of membrane
perturbation. Therefore, the channelrhodopsins that have found
most use in all optical setups (ChR2-H134R, CatCh, ReaChR,
and CheRiff) are those whose enhanced photocurrents have been
achieved with only moderate prolongation compared to wild type
ChR2, which exhibits on and off time constants of ∼0.2 and
∼10 ms respectively (Nagel et al., 2003).
Aside from depolarizing Channelrhodopsins, hyperpolarizing
opsin pumps include halorhodopsin Cl− pumps (e.g., eNpHR3.0)
and bacteriorhodopsin proton pumps (e.g., Arch and ArchT)
(Kandori, 2015). Hyperpolarizing opsins allow selective
suppression and shortening of action potentials (Figure 2B),
and have been utilized for applications such as suppressing
in vivo cardiac motion for high resolution imaging in
zebrafish (Mickoleit et al., 2014). Thanks to distinct absorption
characteristics in comparison with ChR2, a cardiac preparation
expressing both depolarizing and hyperpolarizing opsins can be
selectively stimulated and silenced simply by tuning illumination
wavelength, thereby allowing comprehensive control of the
action potential. While opsins can be expressed independently,
gene-fusion enables formation of protein complexes such as
ChR2-ArchT, allowing co-localization and bi-directional control
of membrane voltage with one protein complex (Nussinovitch
et al., 2014; Streit and Kleinlogel, 2018).
Hyperpolarizing pumps suffer from restricted photocurrent
as one ion is transported per absorbed photon (Berndt et al.,
2011). Anion channelrhodopsins (ACRs), with the potential
for enhanced conductance driven instead by electrochemical
gradients, were first realized by mutation of channelrhodopsins
to infer Cl− conductance, although with some remaining cationic
conductance and slowing of the channel kinetics (Berndt et al.,
2014; Wietek et al., 2014). Subsequently, naturally occurring
ACRs with reduced cationic conductance have been discovered
and cloned (Govorunova et al., 2015). Preliminary studies
indicate that reduced light intensities are required to optically
induce hyper- and repolarizing currents in cardiomyocytes using
these novel ACRs, compared to pumps (Govorunova et al., 2016).
Greater structural and functional understanding of both natural
(Kim et al., 2018) and designed (Kato et al., 2018) ACRs promises
further optimization of inhibitory channels.
Prolonged use and activation of inhibitory pumps or channels
based on conductance of H+ or Cl− can detrimentally alter
intracellular ionic concentrations (Alfonsa et al., 2015; Bernal
Sierra et al., 2018). One promising avenue to potentially
circumvent this limitation is the development of tools which
more closely mimic the resting and repolarization mechanisms
of excitable cells via light activated K+ conductance. Several
approaches have now been tested, including recently published
PAC-K constructs which combine a cAMP-gated K+ channel
with photo-activated nucleotidyl cyclase, allowing optical
silencing of cardiomyocyte (and neuron) activity (Bernal Sierra
et al., 2018). These constructs, however, do not currently allow
for fast responsive control of membrane potential, eliciting
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FIGURE 2 | Optogenetic control of the cardiac action potential. (A) Opsins such as channelrhodopsins, by conducting cations such as H+, Na+, K+, Ca2+ on light
activation, can depolarize the cell membrane and hence initiate or prolong the cardiac action potential. (B) Hyperpolarizing opsins such as Halorhodopsins (Cl−
pumps), Bacteriorhodopsins (H+ pumps) and Anion Channelrhodopsins (I−, Br−, Cl−, F− channels) can shorten or completely suppress the action potential.
hyperpolarization lasting minimally for 100 ms, preventing
dynamic control during the action potential.
Delivery of Opsins in Cardiac Tissue
Optogenetic control requires reliable, rapidly responsive, and
reversible generation of depolarizing and hyperpolarizing
currents by the expression of the light gated ionic transport
proteins. The first barrier to achieving cardiac optogenetic
perturbation therefore is effective delivery and expression of
desired opsins in cardiac preparations. Pioneering cardiac
optogenetic studies in 2010 transgenically expressed ChR2 in
zebrafish (Arrenberg et al., 2010) and mouse (Bruegmann et al.,
2010). ChR2 expressing mouse lines remain prevalent (Quiñonez
Uribe et al., 2018) and interventions such as Cre recombinase
allow powerful research strategies (Wang et al., 2017).
However, requirement for transgenic expression of opsins
is costly, time-consuming and limits clinical application of
optogenetics (Knollmann, 2010). Therefore, other techniques
have been explored exploiting tandem-cell-unit (Jia et al., 2011)
and viral (Abilez et al., 2011; Vogt et al., 2015) delivery of
ChR2 and other opsins. Tandem-cell-unit delivery centers on
the concept where previously non-excitable cells, transfected
to express ChR2, are grafted into cardiomyocyte preparations.
The cells couple to the cardiomyocytes via gap junctional
proteins and act as ‘sparks,’ initiating depolarization of coupled
cardiomyocytes on light stimulation (Jia et al., 2011).
In viral delivery, opsin genes are encoded in lentiviruses,
adenoviruses, or adeno-associated viruses (AAV). Viral methods
allow for tissue or cell selectivity, depending on the promoter
used, and can be directly injected to realize light excitability.
Importantly for future clinical utility of optogenetics, there is
increasing evidence that AAVs can be safely and efficaciously
used in the heart (Bera and Sen, 2017) and systemic viral delivery
can be used to promote cardiac specific ChR2 expression in vivo
(Ambrosi et al., 2019). In wild type mice for example, AAV
injection has shown to result in stable and long lasting ventricular
(Vogt et al., 2015; Bruegmann et al., 2016) and atrial (Bruegmann
et al., 2018) expression of ChR2. However, transfection rates and
consequently optical sensitivity remain variable between treated
hearts, and there is some evidence of chamber discrepancies
with atrial transfection rates lower than ventricular (Vogt et al.,
2015; Bruegmann et al., 2016, 2018). Hence, extensive effort is
ongoing to realize the most effective method to introduce optical
excitability to cardiac tissue (Ambrosi et al., 2015).
Reports that high-level expression of lentiviral-delivered ChR2
in NRVMs is associated with cytotoxicity also need to be carefully
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considered if translational potential of this technology is to
be fully realized. The mechanisms underpinning cytotoxicity
are unclear, with Ca2+ overload and membrane damage being
implicated (Li et al., 2017). Further work on mechanistic insight
into cytotoxicity is required to ensure safe use of ChR2 and other
opsins in cardiac optogenetics.
OPTICAL VOLTAGE AND CALCIUM
SENSORS
Synthetic Sensors
A range of sensors are utilized in optical mapping to image
transmembrane voltage, as well fluctuations in cytosolic
and sarcoplasmic reticulum Ca2+ concentrations (Broyles
et al., 2018). Synthetic sensors are small molecules that
are most commonly introduced to ex vivo hearts via
Langendorff perfusion, or via superfusion to both in vitro
and ex vivo preparations.
The most popular voltage sensors are ‘fast’ synthetic styryl
sensors, such as di-4-ANEPPS and rh-237, which embed within
the plasma membrane, Figure 1. As the transmembrane voltage
changes, for example during the cardiac action potential, these
sensors exhibit fast responding (femto- to picosecond) spectrally
shifted fluorescent output due to shifts in charge state and hence
dipole energy levels (electrochromism) (Loew et al., 1978; Miller,
2016). Longpass filtering the emitted fluorescence beyond the
emission spectra maximum therefore allows recording of optical
signals exhibiting fluorescence intensity proportional to cellular
membrane voltage changes, i.e., optical action potentials (OAP)
(Herron et al., 2012).
On the other hand, intracellular Ca2+ sensors such as rhod-
2AM are designed to internalize within the cell, Figure 1.
They are commonly esterified to neutralize the charge, aiding
intracellular uptake. The ester is then enzymatically cleaved once
in the cell, leaving behind a Ca2+ chelator and a fluorophore. As
Ca2+ is chelated, fluorescence output increases, and subsequently
decreases upon dissociation, reporting the changing [Ca2+] in
the intracellular space where the sensor localizes, either in the
cytosol or sarcoplasmic reticulum (Jaimes et al., 2016).
Genetically Encoded Sensors
Alternatively to small molecule synthetic sensors, voltage and
calcium responsive protein sensors can be genetically encoded to
achieve cell specific indicator expression (Liao et al., 2015; Quinn
et al., 2016). These are collectively termed genetically encoded
voltages/calcium indicators (GEVIs/GECIs), constructed by
the fusion of voltage/Ca2+ sensitive and fluorescent proteins
(Scanziani and Häusser, 2009). Genetic indicators can be used
to independently measure voltage or Ca2+, but can also be
fused to create dual voltage-calcium constructs such as CaViar
(Hou et al., 2014) which combines QuasAr2 (GEVI) with
GCaMP6f (GECI). Furthermore, co-expressed indicator and
actuator pairs offer a unique ability to provide all-genetic, all-
optical electrophysiological study (Chang et al., 2017). The
“Optopatch” platform for example combines genetic indicators
with CheRiff and has been utilized both in establishing all-optical
mouse lines and as a high throughput cardiotoxicity screening
platform for all-optical pacing with simultaneous voltage and
intracellular calcium measurement (Hochbaum et al., 2014;
Dempsey et al., 2016; Björk et al., 2017).
Synthetic vs. Genetically Encoded
Sensors
Genetic indicators rely on conformational changes to directly
alter their fluorescence response or via eliciting processes such
as Forster resonance energy transfer (FRET). Consequently,
compared to the ‘fast’ small-molecule sensors, an important
limiting factor of current genetically encoded indicators is their
response times which are typically in the order of milliseconds
(Kaestner et al., 2015). This can prove problematic when
measuring the sub millisecond phenomena involved in cardiac
depolarization, repolarization and calcium handling (Koopman
et al., 2017). Indeed, OAPs recorded by genetic indicators exhibit
a significantly altered morphology compared to simultaneously
measured OAPs using syntenic sensors (Shinnawi et al., 2015).
Coupled to this, the relatively straightforward application to
ex vivo and in vitro preparations makes synthetic sensors more
commonly utilized in optical mapping studies (Herron et al.,
2012), and to date the pioneering all-optical setups (Table 1).
Synthetic sensors will non-specifically stain all the cell
subpopulations in cardiac preparations. In contrast, genetic
sensors can be successfully utilized in vivo and in vitro to
cell specifically stain cardiomyocytes (or other cell types) (Hou
et al., 2014; Dempsey et al., 2016). They hence allow long-
term, cell specific, imaging of electrical and calcium activity,
currently not possible with synthetic sensors. Furthermore,
synthetic sensors suffer from internalization, phototoxicity and
cytotoxicity making them only suitable for short-term imaging
of cardiac preparations (Kaestner et al., 2015). The extent
to which synthetic sensors exhibit toxicity is dependent on
study specific parameters including experimental model, sensors
concentration and illumination protocols. For example, di-4-
ANBDQBS has been shown to exhibit little phototoxicity even
at high illumination intensities (Kanaporis, 2012). In this case,
the sensor was loaded into guinea pig ventricular preparations
and illumination time was restricted to 1 min. In other studies,
continuous illumination of di-4-ANBDQBS for 10 min showed
significant phototoxic effects compared to a genetic sensor
in both human induced pluripotent stem cell cardiomyocyte
monolayers (Shaheen et al., 2018), and single cells (Streit and
Kleinlogel, 2018). Thus, both of these studies suggest that despite
their slower response kinetics, GEVIS and GECIs are valuable
tools not only for in vivo study but also in situations where
phototoxic effects are prominent, such as cellular monolayers
and single cells (Fast and Kléber, 1994; Broyles et al., 2018;
Streit and Kleinlogel, 2018).
DESIGNING AN ALL-OPTICAL SETUP
The development of a successful all-optical system relies on
a number of key features, unique when compared to single
purpose, single cell, optical mapping or optogenetic setups.
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Light must be delivered to both the opsins and the voltage or
calcium sensors, demanding distinct illumination characteristics.
The possibility of illumination crossover necessitates careful
consideration of sensors, actuators and filtering requirements.
Table 1 summaries opsin-sensors combinations that allow
stimulation of optical actuation, control and imaging in pivotal
all-optical studies.
Opsin and Sensor Compatibility
For an all-optical system, the compatibility of opsins with voltage
and Ca2+ sensors is paramount, as spectral overlap will result in
unwanted crosstalk and perturbation of the cellular membrane.
For example, the absorption spectra of the most commonly used
synthetic voltage sensor di-4-ANEPPS (excitation peak = 475nm)
overlaps with that of ChR2, Figure 3. Therefore, excitation
of di-4-ANEPPS to optically measure voltage can also excite
ChR2, perturbing the membrane potential (Park et al., 2014).
With this spectral congestion in mind, it is not surprising
that the pioneering all-optical setups imaging Ca2+ routinely
used rhod-4AM (Jia et al., 2011), which exhibit less spectral
overlap with ChR2.
The use of opsins or sensors with red-shifted absorption
profiles is the most common solution to spectral congestion. In
general, it is easier for an all-optical system to utilize a red-shifted
sensor, as the further red-shift of fluorescence emission can
then be simply long-pass or band-pass filtered before imaging.
Pittsburgh I (PGH1) is a potentiometric sensor whose absorption
and emission spectra are far red shifted in comparison to di-
4-ANEPPS, with an excitation and emission peak of 608 and
880 nm respectively (in EtOH) (Salama et al., 2005). It was hence
the first sensor used in an all-optical manner with concurrent
opsin excitation and voltage mapping (Park et al., 2014). By
allowing opsin excitation with simultaneous voltage mapping,
this system demonstrated how optogenetics can be used to not
only pace cardiac tissue but crucially also prolong the action
potential by ChR2 excitation during repolarization, a potential
FIGURE 3 | Excitation spectra of the depolarizing opsin ChR2-H134 and
voltage sensitive sensors di-4-ANEPPS and di-4-ANBDQBS. Significant
overlap exists between the excitation spectra of ChR2 and di-4-ANEPPS,
preventing imaging of di-4-ANEPPS without perturbing the membrane
potential of ChR2 expressing cells. However, the red-shifted spectra of
di-4-ANBDQBS does allow for excitation without simultaneous
activation of ChR2.
therapeutic approach (Karathanos et al., 2014), or silence activity
by eNpHR3.0 driven hyperpolarization (Park et al., 2014).
Alongside PGH1, there are red-shifted variants of di-4-
ANEPPS. They include di-4-ANBDQPQ and di-4-ANBDQBS,
which share the same basic structure as di-4-ANEPPS but with
a distinct chromophore and longer linker sizes. The result is red-
shifted absorption and emission spectra, both effectively excited
between 500 and 700 nm (Figure 3) and imaged from 700
to 900 nm (Matiukas et al., 2007). They are hence spectrally
distinct from ChR2. Additionally, ‘blue-shifted’ opsins are being
developed (Lam et al., 2017) which may help avoid spectral
overlap, however, their use may be limited by tissue damage and
penetration depth.
PGH1, di-4-ANBDQPQ, di-4-ANBDQBS and rh-1691 have
all been successfully used in all-optical setups due to their
favorable spectral properties. Table 1 lists potentiometric and
calcium sensors used concurrently with optogenetic control
and gives examples of illumination and filter setups (discussed
in more detail later) that have been employed to minimize
actuator-sensor crosstalk. Despite spectral overlap, sensors such
as di-4-ANEPPS and GCaMP based calcium indicators have
also been used in all-optical setups. However, dual-excitation,
and fluorescence baseline shifts on pulse excitation, result in
the requirement for spatial separation between excitation and
emission areas, or need for extensive pre- and post-acquisition
filtering (Dempsey et al., 2016; Li et al., 2017; Wang et al., 2017).
Illumination Sources
For optical mapping, sensor excitation is most commonly
achieved using LEDs which benefit from narrow wavelength
spectra, long operational lifetimes and low heat emission
(Beacher, 2008), though Tungsten-Halogen lamps,
Mercury/Xeon arc lamps and lasers are also used. Illumination
source is chosen based on a number of characteristics, including
wavelength and power. However, illumination of the sample
in terms of spatial and temporal homogeneity is of paramount
importance for successful optical mapping. In contrast, optical
actuation in optogenetics routinely requires impulse-like signals
(temporal inhomogeneity) delivered to a specific area of the
sample (spatial inhomogeneity). Additionality, a number of
studies have demonstrated the importance of patterned light
delivery to drive conduction dynamics and realize effective
arrhythmia termination (Burton et al., 2015; Crocini et al.,
2016; Feola et al., 2017). Therefore liquid crystal (Schmieder
et al., 2017) and digital micromirror device (DMD) spatial light
modulation coupled to an illumination source such as an LED,
able to uniquely deliver synchronous patterned illumination,
have been extensively used in cardiac optogenetics from its
infancy (Arrenberg et al., 2010). DMDs utilize several hundred
thousand or millions of hinged micrometer sized mirrors to
deliver illumination patterns with high spatial resolution, an
ability that has been key to several optogenetic based discoveries
(Scardigli et al., 2018).
Furthermore, fiber-optic coupled LED (Prando et al., 2018)
and laser-based approaches have been utilized. This has partially
been driven by the potential to incorporate illuminating fibers
in clinically used tools for precise spatial illumination in vivo
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(Klimas and Entcheva, 2014). Devices incorporating micro LED
illumination with photodetectors have also been developed
(Xu et al., 2014), and further optimization of such unique
light delivery strategies is crucial if latent clinical benefits of
optogenetics are to be realized.
Optical Filtering
The use of compatible opsins and sensors to avoid spectral
overlap has already been discussed. However, optical filtering
is still crucial in effective excitation and imaging of samples,
especially when considering the multiple light paths necessary
in the majority of all-optical setups. Single wavelength filters
utilized in all-optical setups can be broadly characterized as
(i) Bandpass filters (ii) Long- or shortpass filters, and (iii)
Dichroic mirrors/beam splitters (Figure 4). An idealized single
wavelength bandpass filter (Figure 4A) absorbs wavelengths
outside a defined window, characterized by a central wavelength
(CWL) and full width half maximum (FWHM). A common use
of bandpass filters in all optical setups is excitation filtering,
where illumination light is filtered before reaching a sample to
narrow spectral bandwidth with a relatively small FWHM filter.
This helps avoid interference with other sensors or actuators
(Jaimes et al., 2016). For example, an effective excitation filter for
red shifted voltage sensor di-4-ANBDQPQ may be a 640/40 nm
(CWL/FWHM) bandpass filter (Scardigli et al., 2018), placed
between the illumination source and sample.
Longpass filters (Figure 4B) will absorb light with a
wavelength below the CWL but will transmit light above this
threshold (with the opposite holding for a shortpass filter with the
same CWL). They therefore do not have an associated FWHM
and are most used as emission filters, absorbing excitation
light wavelengths while conserving the red-shifted fluorescence
emission (Park et al., 2014). In conjunction with removing
excitation light, longpass filtering is also necessary to effectively
measure voltage dependent signals that arise from spectral shift,
e.g., the electrochromic based indicators previously discussed,
as the fluorescence must be imaged away from the emission
maxima. Bandpass filters with red-shifted CWL compared to
excitation wavelengths (and emission maxima if required) can
also be used for emission filtering, i.e., between the sample
and imaging device. For an effective emission bandpass filter,
however, a large FWHM is often desirable to maximize the
photon count at the imaging device, assuming absorbance of
excitation light is maintained (Scardigli et al., 2018). Table 1
summaries excitation and emission filtering setups that have been
implemented in all-optical setups encompassing both voltage and
calcium indicators.
Bandpass and longpass filters interact with light by either
absorbing or transmitting depending on wavelength. Dichroic
mirrors (or beam splitters), however, reflect certain wavelengths
of light. An idealized longpass dichroic mirror for example
(Figure 4C) transmits light with wavelength above the CWL
and reflects (often at an angle of incidence of 45o) wavelengths
below this cut off. Therefore, aside from basic filtering that is also
possible to achieve with longpass and bandpass filters, dichroic
mirrors can be used for important functions such as directing
light paths (Scardigli et al., 2018) and splitting emission in dual
sensor setups to either separate cameras or sections of a single
imaging chip (Dempsey et al., 2016; Wang et al., 2017). The filters
outlined in Figure 4 are known as single wavelength or single
band filters, with one characterizing CWL. In contrast, multiband
filters are characterized by multiple transmission wavelength
regions. They have hence found particular utility in dual optical
mapping setups to simultaneously filter voltage and calcium
emission signals (Wang et al., 2015).
Removing Spectral Deconvolution
Requirement
Problems with spectral overlap can be circumvented by utilizing
optical imaging techniques that are not reliant on fluorescent
sensors, i.e., do not require illumination. On initiation of
the action potential, excitable cells exhibit changing light
FIGURE 4 | Example effect of idealized optical filters on ‘white’ light. Arrows indicate path of light with indicated spectra pre and post filtering. (A) Bandpass filter. All
wavelengths of light, other than those within the transmission window are absorbed. (B) Longpass filter. Light with wavelengths above the central wavelength (CWL)
are transmitted, and all other wavelengths are absorbed. (C) Dichroic mirror. As with the longpass filter, light with wavelengths above the CWL are transmitted. Light
with wavelengths below the CWL is reflected at an angle of incidence, commonly 45
◦
.
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scattering properties, changing contrast (Cohen et al., 1972).
However, with well-thought out setup design such as contrast
enhancing off-axis illumination, the optical changes of the
cell have shown to be a useful (although limited) substitute
to direct sensor imaging of transmembrane voltage (Burton
et al., 2015). Although parameters such as action potential
morphology cannot be accurately recovered, sensor free imaging
allows non-invasive tracking of excitation waves through cellular
monolayers, and simple integration with optogenetic actuators
(Burton et al., 2015). More recently, there has been development
of bioluminescent, rather than fluorescent GEVIs such as the
FRET based LOTUS-V (Inagaki et al., 2017). As bioluminescent
output is stimulated chemically by treatment with a substrate
such as Furimazine rather than optically, no illumination is
required. This avoids the need for spectral separation between
any excitation light and actuators present and facilitates long-
term voltage imaging. When expressed in human induced
pluripotent stem cell cardiomyocytes, LOTUS-V has been shown
to deliver comparable, action potential signals to the synthetic
sensor di-8-ANEPPS, although values such as action potential
duration were prolonged due to the slower response kinetics
(milliseconds) of the FRET response compared to the ‘fast’
synthetic sensors (Inagaki et al., 2017). The use of bioluminescent
sensors in all-optical setups may therefore provide an attractive
alternative to fluorescent GEVIs.
Additionally, novel non-genetic techniques for optical cardiac
excitation based on graphene substrates (Savchenko et al., 2018),
x-ray and ultrasound activated nanoparticles (Berry et al., 2015),
or infrared induced temperature gradients (McPheeters et al.,
2017) can act as a solution to spectral overlap and to realize deep
tissue activation. These optical pacing strategies, however, do not
share some of the unique advantages that genetically induced
optical de- and hyperpolarization allows, most prominently
precise control over wave dynamics or cell-specific activation.
Imaging
As with many other areas of the life sciences, cardiac optical
mapping has benefitted from continued advancement of camera
technology. Photodiode arrays (PDAs) were utilized in the
early optical mapping experiments that moved beyond single
photomultiplier tubes (Salama et al., 1987). PDAs benefit from
a large dynamic range (as the PDA is made up of large individual
diodes) and enhanced sampling rates. Low fractional changes in
sensor fluorescence and the sub millisecond dynamics of cardiac
electrical activity make these invaluable features for successful
optical mapping (Efimov and Salama, 2012).
However, due to the physical arrangement of individual
diodes, the maximal spatial resolution of a PDA is more limited
compared to charge-coupled device (CCD) and complementary
metal oxide semiconductor (CMOS) cameras. In modern setups
therefore, CCD and CMOS cameras dominate (Gloschat et al.,
2018; Wen et al., 2018). Developments such as electron-
multiplication in CCD cameras, and 2nd generation back
illuminated ‘scientific’ CMOS cameras have helped improve
dynamic ranges and noise levels of these cameras, while
enhanced compatibility with standard computer interfaces such
as USB-3 help alleviate previously prohibitive costs (Boukens
and Efimov, 2014). Crucially, these cameras offer much
higher spatial resolutions than possible with PDAs, capable of
capturing > 10,000 pixel images at kHz sampling rates (Yu et al.,
2017). The choice of imaging device for an all-optical setup
does not differ considerably from a traditional optical mapping
setup, and PDAs, CCD cameras and CMOS cameras have all
been successfully utilized. Another important consideration is
quantum efficiency of imaging devices in the far-red to near
infrared wavelengths, if using red-shifted sensors.
Dual Voltage–Calcium All Optical Setups
Optical mapping of preparations dual loaded with both voltage
and calcium sensors offers unique insights into the interplay
between the cardiac action potential and Ca2+ handling (Myles
et al., 2012). Achieving dual voltage-calcium optical mapping
requires careful consideration of sensors spectra and filtering
requirements. Addition of optical actuation, with its unique
spectral, spatial, and temporal illumination requirements, further
complicates the setup. Therefore to date, optical setups utilizing
both voltage and calcium sensors have been shown to image the
two indicators separately or sequentially (Klimas et al., 2016). In
all-optical setups with simultaneous voltage-calcium imaging and
optical pacing, spatial separation was necessary between pacing
site and imaged area (Dempsey et al., 2016).
Computational Post-processing
In lieu of physical methods, computational methods can be
used to overcome the spectral congestion that arises from
optogenetic manipulation of optically mapped samples. However,
it is important to note that these do not overcome undesired
modulation of the membrane potential. A simple example is
automatic identification and removal of optical pacing peaks by
the application of several filters (Feola et al., 2017) or image
frame removal (O’Shea et al., 2019). This is an effective strategy
providing filtering/frame removal does not alter the fluorescence
signal properties at pertinent times, and so ideally requires
either temporal or spatial separation between pulsing peaks and
fluorescence output.
Light pulses, however, can be more prohibitive to optical
mapping analysis if pulses are applied during relevant phases of
the cardiac cycle. For example, when pulses of light are delivered
during the plateau and repolarization of the action potential,
despite optical filtering attempts to avoid crosstalk, blue and
green pulses can cause baseline shift in OAPs. As demonstrated
by Park et al. (2014), to compensate for this, ‘gap compensation’
modeling procedures can be implemented. Briefly, this involves
construction of a perturbation model of the optical emission
(Fbluepulse) like shown in Equation 1
Fbluepulse = Ffit + A.
e−
(
t−tpulse
)
τslow − e−
(
t−tpulse
)
τfast
2 (1)
where Ffit is the model of a control action potential without
blue light illumination, A is a constant, t is time, tpulse is
start time of the light pulse, and τslow and τfast are decay
constants. The repolarization phase of the perturbed OAP
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therefore is modeled by least square fitting a bi-exponential
decay from the start of the blue light pulse allowing recovery
of the OAP during optogenetically induced action potential
prolongation (Park et al., 2014).
CONTACTLESS ACTUATION AND
ELECTROPHYSIOLOGY
Both in basic research and clinically, electrode-based techniques
for pacing and stimulation require direct or close contact to
cardiac tissue. Although extensively exploited and effective, these
actuation methods are not without limitation. The direct contact
between electrodes and tissue can promote electrochemical
reactions and reactive oxygen species formation. Conversely
in some situations, for example in cardioversion strategies
(Nyns et al., 2017) or in cardiomyocyte monolayers to improve
signal quality (Lapp et al., 2017), simultaneous activation
of the large areas is desired rather than at a single site. If
the activation region needs to be changed then electrodes
must be physically moved, limiting spatial flexibility and
throughput. From a clinical perspective, implantable pacemaker
and defibrillation devices are highly energy consuming, tissue
damaging, prone to post-implantation complications and
can cause psychological distress and reduced quality of life
(Bruegmann et al., 2016; Israelsson et al., 2018).
Optogenetic pacing therefore is one of a few biological
strategies being explored as a replacement for traditional
pacemaker devices (Rosen et al., 2011) but undoubtably
its most immediate beneficial quality is the ability realize
unique basic research possibilities. Optogenetic opsins can
be delivered to specific cell types (Hulsmans et al., 2017;
Wang et al., 2017), providing novel research strategies,
and promoting precise, repeatable and coordinated activation
patterns. Conversely, by changing illumination conditions or
the spatial arrangement of opsins expression, simultaneous
excitation/suppression of large areas can be achieved. This can
be applied in cellular monolayers, where concurrent activation
can enhance signal quality, or in cardioversion strategies to
terminate arrhythmias (Bruegmann et al., 2018). Contactless
actuation avoids tissue damage due to the lack of tissue-electrode
interface and can be realized in high-throughput applications
such as multi-well cellular assays, discussed in more detail
later (Klimas et al., 2016).
Optical mapping offers several clear advantages compared
to electrode recording techniques. The spatial resolution
achievable with optical mapping systems greatly outperforms
multi-electrode array mapping systems. Furthermore, optical
imaging can allow detailed, direct and multi-parameter
investigation of voltage and calcium dynamics, whereas electrode
techniques often make indirect measurements such as field
potentials, where signals can be corrupted by noise and can alter
significantly over time due to changes in electrode positioning
or the maintenance of contact. Therefore, despite some
notable disadvantages of optical study including requirement
of contraction uncouplers and inability to perform in vivo
experiments (Boukens and Efimov, 2014), optical mapping
techniques have seen growing use, even prior to transformative
capabilities of optical stimulation was made available. The
recent combination of actuation and measurement in all-optical
setups has therefore, in a relatively short timeframe, delivered
remarkable insights into optogenetic pacing (Nussinovitch
and Gepstein, 2015a), cell targeting (Wang et al., 2017) and
arrhythmia termination (Feola et al., 2017); advancing basic
understand and enhancing the prospect of future clinically
relevant optical therapies.
EFFECTS OF LIGHT PACING ON ACTION
POTENTIAL MORPHOLOGY AND
PROPAGATION
For further implementation of optogenetic technologies, detailed
understanding of whether optogenetic actuation affects cardiac
electrical signal morphology is required. All-optical systems
are uniquely advantageous for such investigations, as they are
able to report key EP signal parameters for comparison against
established techniques, while also providing high spatio-temporal
recording of cardiac activation (Entcheva and Bub, 2016).
Recent work using human stem cell-derived cardiomyocytes
expressing commercial optogenetic constructs OptoPatch and
CaViar have demonstrated that optogenetic modulation does
not significantly alter single cell electrophysiological properties
(Björk et al., 2017). Furthermore, optogenetic manipulation
of neonatal rat ventricular myocyte monolayers expressing
ChR2 indicate unaltered conduction velocity, action potential
duration and upstroke velocity compared to control cells,
using either optogenetic or electrical actuation (Li et al.,
2017). Computational insights have for the most part agreed
with experimental findings by showing similar action potential
morphologies and cell type dependent variability (Williams
and Entcheva, 2015). Nevertheless, fundamental differences in
electrical and optogenetic stimulation exist. Electrical current
injection is traditionally achieved with a rectangular pulse
delivered at short pulse widths of 2–10 ms (Myles et al., 2012;
Holmes et al., 2016). ChR2 photocurrent exhibits slower onset
kinetics, meaning longer pulse timescales can be required to reach
excitation threshold (Williams and Entcheva, 2015). The effects
of these stimulation differences on in vitro and in vivo cardiac
electrophysiology require further examination.
APPLICATIONS OF ALL OPTICAL
CARDIAC ELECTROPHYSIOLOGY
All-optical systems, in their relatively short period of existence,
have expanded our understanding of cardiac pathophysiology
thanks to their high spatio-temporal resolution and unique
ability for targeted tissue excitation. Indeed, by optically
mapping voltage in transgenic mice expressing ChR2,
threshold excitation and vulnerable areas for proarrhythmic
focal ectopic activity has been determined (Zaglia et al.,
2015). All-optical setups have allowed demonstration and
potential for utility of ChR2 mediated resynchronization
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(Nussinovitch and Gepstein, 2015a) and have crucially informed
the production of local rather than global areas of conduction
block using patterned illumination. The patterned illumination
shows similar success in arrhythmia termination but at
lower energy costs than global activation (Crocini et al.,
2016; Feola et al., 2017). However, whether optogenetic
approaches confer energy reduction benefits, over established
and effective electrode technologies requires detailed assessment
in future studies.
Previously, optical mapping of arrhythmia dynamics in whole
hearts has allowed mechanistically driven choice of patterned
illumination in an ‘open-loop’ fashion - information based
on previous recordings being used to dictate illumination
patterns. Although this proved similarly effective as global
illumination, there is reliance on consentient arrhythmia
dynamics between hearts (Crocini et al., 2016). However,
recent advancements including utilization of DMD illumination
technology and high-speed data recording have demonstrated
the potential of ‘closed-loop’ all-optical EP. Here, conduction
disorders such as atrioventricular block can be detected by
optical mapping and corrected by optical stimulation of
ChR2 in real time. Real-time intervention can also conversely
be used to setup and then study conduction abnormalities
such as re-entry. These abilities make ‘closed-loop’ systems
potentially vital going forward, allowing all-optical research
in experimental models that is tunable in a manner hitherto
only afforded by computational modeling, and at much
reduced timescales (Scardigli et al., 2018). Similarly, all-
optical control and output has shown the feasibility of
engineering bioelectric tissues capable of complex information
processing and in which all constituent parts are fully
characterized (McNamara et al., 2016).
A major avenue for use of all-optical setups is the delivery
of high-throughput platforms for cardiotoxicity screenings of
candidate drug compounds (Klimas et al., 2016; Streit and
Kleinlogel, 2018). These platforms are crucial in the context
of the comprehensive in vitro pro-arrhythmia assay (CiPA)
initiative – the recognition that cardiotoxicity screening should
not focus solely on hERG channel interactions and must
use experimental as well as computational methods (Fermini
et al., 2016). All-optical methods are distinctly suited to the
changing requirements of cardiotoxicity drug screening. As
highlighted, the lack of requirement for direct contact makes
optical actuation and optical recording much easier to scale to
high-throughput parallelized applications, crucial for screening
multiple drugs. As the reported voltage signals result from
the sum of all ionic currents, significant alterations in any
channel or pump function (not just hERG/IKr) in response
to a drug will be evident, while Ca2+ handling abnormalities
can also be screened with the use of appropriate sensors
(Dempsey et al., 2016; Klimas et al., 2016). If specific channels
warrant further investigation, all-optical methods can still be
utilized by expression of channels in cells otherwise void of
the ionic channels of interest (Streit and Kleinlogel, 2018),
and the scalability of optical methods means analysis of
other models apart from cell cultures may be achievable in
the near future.
CONCLUSION AND FUTURE
DIRECTIONS
Optogenetics is a technique that has developed into an immensely
useful tool in basic cardiac research with clear, though as of
yet unrealized, clinical potential (Entcheva, 2013). Fusion of
optogenetics with optical mapping has been made possible by the
substantial technical considerations and advances summarized in
this review. All-optical electrophysiology, and indeed the field
of cardiac optogenetics in general, however, remains a relatively
new technique with several opportunities to further advance our
understanding of electrical function in the heart.
Recent demonstration of ‘closed-loop’ all-optical investigation
opens up a plethora of exciting opportunities for application of
this exciting technology to key research questions, relevant in
health and disease. ‘Closed-loop’ all-optical investigation studies
could deliver faster, more physiologically relevant tools than even
the most sophisticated computational cardiac models.
In contrast to cardiac research, optogenetics is widespread
in neuroscience (Adamantidis, 2015). Effects on heart function
and coupling of neurons and cardiac cells are often measured
outcomes of neuromodulation. However, cardiac effects of
optical neuromodulation are potentially limited to simply
beating rate measurements (Nussinovitch and Gepstein, 2015b)
or monitored using traditional techniques, with only isolated
examples of optical mapping neuronal-cardiac effects (Dong
et al., 2016). The combination of optical neuromodulation
with all-optical cardiac electrophysiology could deliver
unique insights into control of the heart by the nervous
system (Wengrowski et al., 2015).
For optogenetic-based therapy to ever be realized in clinical
practice, several technological and biological advances need
to be implemented. These include novel methods for light
and gene delivery to in vivo cardiac tissue, wireless control
of implantable devices (Gagnon et al., 2017), and advanced
materials uniquely designed for use in bio-integrated electronic
circuits (Fang et al., 2016). However, regardless of future clinical
utility, implementation of optogenetics in all-optical imaging
systems has already proved a unique and transformative tool for
cardiac research and will continue to be used in the study of the
physiology and pathophysiology of the heart.
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